Efficacy of lamotrigine add-on therapy in severe partial epilepsy in adults with drop seizures and secondary bilateral synchrony on EEG

Epileptic Disorders

Volumn 3, Issue 3, 2001, Pages 151-156

  Bisulli, F ^a   Baruzzi, A ^a   Rosati, A ^a   Riva, R ^a   Avoni, P ^a   Cerullo, A ^a   Tinuper, P ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Epileptic drop attacks; Lamotrigine; Secondary bilateral synchrony

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADD ON THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; ELECTROENCEPHALOGRAM; FEMALE; FOCAL EPILEPSY; GENERALIZED EPILEPSY; HUMAN; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT;

ADULT; ANTICONVULSANTS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSIES, PARTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; SYNCOPE; TRIAZINES;

EID: 0034776082     PISSN: 12949361     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Drop attacks: An ominous change in the evolution of partial epilepsy
2. An analytic study of epileptic falls
3. Generalized cortico-reticular epilepsies. Some consideration of the pathophysiology of generalized bilaterally synchrony spike and wave discharge
4. Clinical and EEG features of partial epilepsy with secondary bilateral synchrony
5. Epileptic drop attacks in partial epilepsy. Clinical features, evolution and prognosis
6. Complex partial seizures of frontal lobe origin
7. Symptomatic partial epilepsies with secondary bilateral synchrony: Differentiation from symptomatic generalized epilepsies of the Lennox-Gastaut type
8. Lamotrigine: A review of its pharmacological properties and clinical efficacy in epilepsy
9. Lamotrigine: Mechanisms of action
10. Lamotrigine
11. An overview: Efficacy of lamotrigine
12. Lamotrigine in the treatment of childhood epilepsy
13. Lamotrigine in treatment of 120 children with epilepsy
14. Lamotrigine: A review of antiepileptic efficacy
15. Lamotrigine for the treatment of epilepsy in childhood
16. Lamotrigine: Clinical experience in 93 patients with epilepsy
17. Lamotrigine adjunctive therapy in childhood epileptic encephalopathy (the Lennox-Gastaut syndrome)
18. Double-blind cross-over trial of lamotrigine (Lamictal) as add-on therapy in intractable epilepsy
19. Controlled trial of lamotrigine (Lamictal) for refractory partial seizures
20. A randomized, double-blind, placebo-controlled, crossover, add on trial of lamotrigine in patients with treatment resistant partial seizures
21. A randomized, double-blind, placebo-controlled, add-on trial of lamotrigine in patients with severe epilepsy
22. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures
23. Double-blind, placebo-controlled crossover study of lamotrigine in treatment-resistant partial seizures
24. Add-on treatment with lamotrigine for intractable partial epilepsy: A placebo-controlled cross-over trial
25. Outcomes of add-on treatment with lamotrigine in partial epilepsy
26. Lamotrigine therapy for partial seizures: A multicenter, placebo-controlled, double-blind, cross-over trial
27. Lamotrigine: An antiepileptic agent for the treatment of partial seizures
28. Controlled trial of lamotrigine (Lamical) for treatment resistant partial seizures
29. Acute effects of lamotrigine (BW430C) in persons with epilepsy
30. The effects of lamotrigine, a novel anticonvulsant, on interictal spikes in patients with epilepsy
31. Co-existence of focal and bilateral diffuse paroxysmal discharges in epileptics
32. The occurrence of generalized (centrencephalic) and focal seizure patterns in the same patients
33. Depth EEG findings in epileptics with generalized spike-wave complexes
34. Lamotrigine add-on therapy in focal epilepsy: Electroencephalographic and neuropsychological evaluation
35. Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: A computerised analysis
36. Standardisation of a self-report questionnaire for use in evaluating cognitive, affective and behavioural side-effects of anti-epileptic drug treatments
37. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy
38. The Lamictal Lennox-Gastaut study group Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome
39. The efficacy of lamotrigine on seizure control in 34 children, adolescents and young adults with intellectual and physical disability
40. Intractable epilepsy in children: The efficacy of lamotrigine treatment, including non-seizure-related benefits
41. Lamotrigine as add-on drug in the management of Lennox-Gastaut syndrome
42. Lamotrigine for startle-induced seizures